South Africa makes pharma a ‘designated’ industry
April 16, 2012Manufacturing and Production DTI, Rob Davies, South Africa
The government of South Africa has said it will only buy certain pharmaceutical products that are manufactured in domestic facilities, …
New health boards met with cautious optimism
April 16, 2012Sales and Marketing NHS, king's fund
The new joined-up health and wellbeing boards have been well received by The King’s Fund, but the think tank warns …
Merck signs deal with venture capitalists
April 16, 2012Research and Development, Sales and Marketing Flagship Ventures, Merck
Merck has entered a deal with a US venture capital firm specialising in life sciences to help build the manufacturer’s …
Aesica approval sets up further US expansion
April 16, 2012Manufacturing and Production Aesica, FDA
UK contract manufacturer and ingredient supplier Aesica says its manufacturing facility at Queenborough has successfully passed its first FDA inspection …
Diabetes UK launches new peer support service
April 16, 2012Diabetes UK, diabetes, peer support
Diabetes UK has launched a new support service that puts people with diabetes in touch with others who have the …
Senior team moves at ROCK medical communications
April 16, 2012Business Services, Medical Communications, Sales and Marketing Rock Medical Communications
ROCK medical communications has appointed Eric Hansen as director and promoted Clare Pressney to associate director. Most recently Hansen spent …
MSI appoints new partner
April 16, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI Consultancy, Sanofi, appointment
Pharma consultancy firm MSI has announced the appointment of a new partner. Steve Mather takes up this senior position with …
UK government invests in new radiotherapy treatment
April 16, 2012Sales and Marketing Cancer, Photon beam therapy, Proton beam therapy, prostate cancer, radiotherapy
The government is to invest £250 million in a cutting-edge radiotherapy treatment that should benefit 1,500 cancer patients in the …
Cloud computing ‘eagerly anticipated’ by healthcare
April 16, 2012Medical Communications, Sales and Marketing Cloud Computing, digital, healthcare
The use of cloud computing in healthcare is expected to grow significantly in the coming years, but developed countries may …
Takeda to buy gout specialist URL Pharma for $800m
April 16, 2012Research and Development, Sales and Marketing R&D, Takeda, acquisition, gout
Takeda is set to purchase URL Pharmaceuticals for $800 million, helping offset the loss of its blockbuster ulcer drug Prevacid. …
Access to new cancer drugs limited in Brazil and Mexico
April 13, 2012Sales and Marketing Brazil, Cancer, Mexico, avastin, emerging markets
Between one-quarter and one-third of patients in Brazil and Mexico who are eligible for treatment with new cancer drugs do …
Januvia gains renal impairment licence in UK
April 13, 2012Sales and Marketing Januvia, MSD, Merck, diabetes, renal impairment
Merck’s Januvia has had its licence extended in the UK for patients with moderate to severe renal impairment. The drug …
UCB launches ‘Parkinson’s Well-Being Map’
April 13, 2012Medical Communications Parkinson's disease, UCB
UCB has launched a new visual tool to help people with Parkinson’s Disease to discuss their health and symptoms with …
Innovating in China’s pharma market
April 12, 2012Research and Development AstraZeneca, China, R&D, Steve Yang, emerging markets
The challenges that China and the wider Asia region face in healthcare represent big opportunities for multinational pharma companies. Cases of …
ViiV Healthcare appoints Just:: Health PR
April 12, 2012Medical Communications, Sales and Marketing HIV/AIDS, Just::, PR, ViiV
ViiV Healthcare has appointed Just:: Health PR to work on an integrated political and public relations initiative that will engage …
Roche on target despite European shrinkage
April 12, 2012Sales and Marketing Illumina, Q1 2012, Roche
Roche saw its business grow in the first three months of the year, thanks to strong showings from hepatitis C …
EMA backs full access to trial data
April 12, 2012Business Services, Research and Development, Sales and Marketing EMA, clinical trial data, data disclosure, regulatory affairs, transparency
The European Medicines Agency says it wants to open up access to full clinical trial data, but warns that some …
immatics appoints Dr Rainer Kramer as its new
 chief business officer
April 12, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
immatics biotechnologies, a biopharma company developing therapeutic cancer vaccines, has appointment Dr Rainer Kramer as its new chief business officer. …
Algeta to co-promote Alpharadin in US
April 12, 2012Sales and Marketing Algeta, Bayer, prostate cancer
Algeta has exercised its option to co-promote Alpharadin for the treatment of cancer patients with bone metastases in the United …
Humira gains European licence for ulcerative colitis
April 11, 2012Sales and Marketing Humira, ulcerative colitis
Abbott’s Humira has gained European approval to treat ulcerative colitis, adding to its six existing licences. It can now …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
